24 May 2013
Keywords: ardana, posts, strong, ph, ii, teverelix, la
Article | 22 December 2006
Scottish drugmaker Ardana says that preliminary results from a Phase II study of its lead development compound, the gonadotrophin-releasing
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
22 December 2006
23 May 2013
© 2013 thepharmaletter.com